1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Others
1.3 Market by Application
1.3.1 Global Nuclear Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Medicine Market Perspective (2016-2027)
2.2 Nuclear Medicine Growth Trends by Regions
2.2.1 Nuclear Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nuclear Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Nuclear Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Nuclear Medicine Industry Dynamic
2.3.1 Nuclear Medicine Market Trends
2.3.2 Nuclear Medicine Market Drivers
2.3.3 Nuclear Medicine Market Challenges
2.3.4 Nuclear Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Medicine Players by Revenue
3.1.1 Global Top Nuclear Medicine Players by Revenue (2016-2021)
3.1.2 Global Nuclear Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nuclear Medicine Revenue
3.4 Global Nuclear Medicine Market Concentration Ratio
3.4.1 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Revenue in 2020
3.5 Nuclear Medicine Key Players Head office and Area Served
3.6 Key Players Nuclear Medicine Product Solution and Service
3.7 Date of Enter into Nuclear Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Medicine Breakdown Data by Type
4.1 Global Nuclear Medicine Historic Market Size by Type (2016-2021)
4.2 Global Nuclear Medicine Forecasted Market Size by Type (2022-2027)
5 Nuclear Medicine Breakdown Data by Application
5.1 Global Nuclear Medicine Historic Market Size by Application (2016-2021)
5.2 Global Nuclear Medicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Nuclear Medicine Market Size (2016-2027)
6.2 North America Nuclear Medicine Market Size by Type
6.2.1 North America Nuclear Medicine Market Size by Type (2016-2021)
6.2.2 North America Nuclear Medicine Market Size by Type (2022-2027)
6.2.3 North America Nuclear Medicine Market Size by Type (2016-2027)
6.3 North America Nuclear Medicine Market Size by Application
6.3.1 North America Nuclear Medicine Market Size by Application (2016-2021)
6.3.2 North America Nuclear Medicine Market Size by Application (2022-2027)
6.3.3 North America Nuclear Medicine Market Size by Application (2016-2027)
6.4 North America Nuclear Medicine Market Size by Country
6.4.1 North America Nuclear Medicine Market Size by Country (2016-2021)
6.4.2 North America Nuclear Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nuclear Medicine Market Size (2016-2027)
7.2 Europe Nuclear Medicine Market Size by Type
7.2.1 Europe Nuclear Medicine Market Size by Type (2016-2021)
7.2.2 Europe Nuclear Medicine Market Size by Type (2022-2027)
7.2.3 Europe Nuclear Medicine Market Size by Type (2016-2027)
7.3 Europe Nuclear Medicine Market Size by Application
7.3.1 Europe Nuclear Medicine Market Size by Application (2016-2021)
7.3.2 Europe Nuclear Medicine Market Size by Application (2022-2027)
7.3.3 Europe Nuclear Medicine Market Size by Application (2016-2027)
7.4 Europe Nuclear Medicine Market Size by Country
7.4.1 Europe Nuclear Medicine Market Size by Country (2016-2021)
7.4.2 Europe Nuclear Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Market Size (2016-2027)
8.2 Asia-Pacific Nuclear Medicine Market Size by Type
8.2.1 Asia-Pacific Nuclear Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nuclear Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nuclear Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Nuclear Medicine Market Size by Application
8.3.1 Asia-Pacific Nuclear Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nuclear Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nuclear Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Nuclear Medicine Market Size by Region
8.4.1 Asia-Pacific Nuclear Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nuclear Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nuclear Medicine Market Size (2016-2027)
9.2 Latin America Nuclear Medicine Market Size by Type
9.2.1 Latin America Nuclear Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Nuclear Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Nuclear Medicine Market Size by Type (2016-2027)
9.3 Latin America Nuclear Medicine Market Size by Application
9.3.1 Latin America Nuclear Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Nuclear Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Nuclear Medicine Market Size by Application (2016-2027)
9.4 Latin America Nuclear Medicine Market Size by Country
9.4.1 Latin America Nuclear Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Nuclear Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Market Size (2016-2027)
10.2 Middle East & Africa Nuclear Medicine Market Size by Type
10.2.1 Middle East & Africa Nuclear Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nuclear Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nuclear Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Nuclear Medicine Market Size by Application
10.3.1 Middle East & Africa Nuclear Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nuclear Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nuclear Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Nuclear Medicine Market Size by Country
10.4.1 Middle East & Africa Nuclear Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nuclear Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Details
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Nuclear Medicine Introduction
11.1.4 GE Healthcare Revenue in Nuclear Medicine Business (2016-2021)
11.1.5 GE Healthcare Recent Development
11.2 Bracco Imaging
11.2.1 Bracco Imaging Company Details
11.2.2 Bracco Imaging Business Overview
11.2.3 Bracco Imaging Nuclear Medicine Introduction
11.2.4 Bracco Imaging Revenue in Nuclear Medicine Business (2016-2021)
11.2.5 Bracco Imaging Recent Development
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Details
11.3.2 Mallinckrodt Business Overview
11.3.3 Mallinckrodt Nuclear Medicine Introduction
11.3.4 Mallinckrodt Revenue in Nuclear Medicine Business (2016-2021)
11.3.5 Mallinckrodt Recent Development
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Company Details
11.4.2 Lantheus Medical Imaging Business Overview
11.4.3 Lantheus Medical Imaging Nuclear Medicine Introduction
11.4.4 Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2016-2021)
11.4.5 Lantheus Medical Imaging Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Nuclear Medicine Introduction
11.5.4 Bayer Revenue in Nuclear Medicine Business (2016-2021)
11.5.5 Bayer Recent Development
11.6 Triad Isotopes
11.6.1 Triad Isotopes Company Details
11.6.2 Triad Isotopes Business Overview
11.6.3 Triad Isotopes Nuclear Medicine Introduction
11.6.4 Triad Isotopes Revenue in Nuclear Medicine Business (2016-2021)
11.6.5 Triad Isotopes Recent Development
11.7 Nordion
11.7.1 Nordion Company Details
11.7.2 Nordion Business Overview
11.7.3 Nordion Nuclear Medicine Introduction
11.7.4 Nordion Revenue in Nuclear Medicine Business (2016-2021)
11.7.5 Nordion Recent Development
11.8 Jubilant Pharma
11.8.1 Jubilant Pharma Company Details
11.8.2 Jubilant Pharma Business Overview
11.8.3 Jubilant Pharma Nuclear Medicine Introduction
11.8.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2016-2021)
11.8.5 Jubilant Pharma Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Nuclear Medicine Introduction
11.9.4 Eli Lilly Revenue in Nuclear Medicine Business (2016-2021)
11.9.5 Eli Lilly Recent Development
11.10 SIEMENS
11.10.1 SIEMENS Company Details
11.10.2 SIEMENS Business Overview
11.10.3 SIEMENS Nuclear Medicine Introduction
11.10.4 SIEMENS Revenue in Nuclear Medicine Business (2016-2021)
11.10.5 SIEMENS Recent Development
11.11 China Isotope & Radiation
11.11.1 China Isotope & Radiation Company Details
11.11.2 China Isotope & Radiation Business Overview
11.11.3 China Isotope & Radiation Nuclear Medicine Introduction
11.11.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2016-2021)
11.11.5 China Isotope & Radiation Recent Development
11.12 Dongcheng
11.12.1 Dongcheng Company Details
11.12.2 Dongcheng Business Overview
11.12.3 Dongcheng Nuclear Medicine Introduction
11.12.4 Dongcheng Revenue in Nuclear Medicine Business (2016-2021)
11.12.5 Dongcheng Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
